Propiverine
As of the edition of 20 October 2026, Propiverine is a small molecule: marketed, first approved in 2017 (CA).
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 2017
- Kind
- Small molecule
- Brand name
- Mictoryl
- First approved
- 5 January 2017 (CA)
- Approvals on record
- 5 in 3 regions
- Holder of the most recent approval
- Italfarmaco; 3 holders in all
- Registered trials
- 10, 0 stopped early
- Disease areas
- Pregnancy and women's health; Urinary and reproductive; Mental health; Nervous system
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase not stated | 6 | 4 | 2 | 0 |
| Phase 2 | 1 | 1 | 0 | 0 |
| Phase 3 | 1 | 1 | 0 | 0 |
| Phase 4 | 2 | 2 | 0 | 0 |
| All trials | 10 |